dm+d
57752001
Articles
Implementing pharmacogenomic testing for aminoglycosides
24 November 2023
Patients with mitochondrial variants have an increased risk of deafness with gentamicin, amikacin, tobramycin and neomycin. Guidance on testing is provided.Gentamicin products: information for supporting intrathecal risk assessment
11 August 2022
Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administrationSafety in Lactation: Non-beta lactam antibiotics and antibacterials
8 September 2021
To be used in conjunction with individual drug entries for specific information and guidance. Aminoglycosides Only small or negligible amounts of aminoglycosides are found in…How should medicines be dosed in children who are obese?
28 May 2021
Review on how to calculate medicine doses in children who are obese which includes a table on commonly prescribed medicines.Safety in Lactation: Anti-infective eye preparations
30 October 2020
Anti-infective preparations for ophthalmic use have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. Systemic absorption from eye drops…Lactation Safety Information
Parenteral
Parenteral
-
Limited published evidence of safety
Small amounts in breast milk
Minimal absorption from the infant's GI tract, although some reports of small amounts in neonatal serum
24 September 2020
For ophthalmic use
For ophthalmic use
24 September 2020
For use in the ear
For use in the ear
There are no additional risks when used in combination aural products containing hydrocortisone
24 September 2020